MedTrace Logo

Prospective Study on Artelon® Tissue Reinforcement in Repair of Chronic Ruptures and Re-ruptures of the Achilles Tendon

NCT01237613 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2015-07-22

Study results available
· View outcomes & findings →

Summary

The aim of this study is to evaluate the surgical and clinical outcome of Artelon® Tissue Reinforcement in repair of chronic ruptures or re-ruptures of the Achilles tendon, with regard to lower leg and foot function, pain and quality of life.

Conditions

  • Achilles Tendon Rupture

Interventions

DEVICE

Artelon

Artelon Tissue Reinforcement

Sponsors & Collaborators

  • Artimplant AB

    collaborator INDUSTRY

  • Orthopedic Foot and Ankle Center, Ohio

    lead OTHER

Principal Investigators

  • Terrence M Philbin, DO · Orthopedic Foot and Ankle Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2014-02-28
Completion
2014-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01237613 on ClinicalTrials.gov